Publications by authors named "Thomas Burkhardt"

Claim this Profile
S
SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individuals.
Simone Hoffmann, Alina Seidel, Carolin Ludwig, Christiane Vieweg, Rebecca Müller, Thomas Burkhardt

Transfusion· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.
Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Thomas Burkhardt

J Clin Invest· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Sixten Körper, Bernd Jahrsdörfer, Victor M Corman, Jan Pilch, Patrick Wuchter, Thomas Burkhardt

Transfus Med Hemother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of irradiated and non-irradiated plateletpheresis concentrates stored in platelet additive solution.
Rainer Moog, Remo Rothe, Nicole Arlt, Thomas Burkhardt

Transfus Apher Sci· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin G levels during collection of large volume plasma for fractionation.
Thomas Burkhardt, Remo Rothe, Rainer Moog

Transfus Apher Sci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors.
Hans-Gert Heuft, Eike Fischer, Tina Weingand, Thomas Burkhardt, Gerda Leitner

Transfus Med Hemother· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future.
Brian Godman, Anna Bucsics, Thomas Burkhardt, Jutta Piessnegger, Manuela Schmitzer

Front Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries.
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer, Rickard E Malmström

Expert Rev Pharmacoecon Outcomes Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policies to enhance prescribing efficiency in europe: findings and future implications.
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Thomas Burkhardt

Front Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
Wolfgang C Winkelmayer, Margaret R Stedman, Michaela Pogantsch, Peter Wieninger, Anna Bucsics, Thomas Burkhardt

Pharmacoepidemiol Drug Saf· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Thomas Burkhardt

Expert Rev Pharmacoecon Outcomes Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt

Pharmaceuticals (Basel)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries.
Brian Godman, Anna Bucsics, Thomas Burkhardt, Manuela Schmitzer, Björn Wettermark

Expert Rev Pharmacoecon Outcomes Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of reimbursement changes on statin use among patients with diabetes in Austria.
Wolfgang C Winkelmayer, Markus Asslaber, Anna Bucsics, Thomas Burkhardt, Alexandra Schautzer

Wien Klin Wochenschr· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.
Brian Godman, Thomas Burkhardt, Anna Bucsics, Björn Wettermark, Peter Wieninger

Expert Rev Pharmacoecon Outcomes Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into recent reforms and initiatives in Austria: implications for key stakeholders.
Brian Godman, Anna Bucsics, Thomas Burkhardt, Alan Haycox, Hans Seyfried

Expert Rev Pharmacoecon Outcomes Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of complement activation during membrane-based plasmapheresis procedures.
Thierry Burnouf, Michel Eber, Daniel Kientz, Jean-Pierre Cazenave, Thomas Burkhardt

J Clin Apher· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual cell content in plasma produced by three centrifugal apheresis procedures.
Thierry Burnouf, Claudia Kappelsberger, Kerstin Frank, Thomas Burkhardt

Transfusion· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein composition and activation markers in plasma collected by three apheresis procedures.
Thierry Burnouf, Claudia Kappelsberger, Kerstin Frank, Thomas Burkhardt

Transfusion· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis